GENELABS TECHNOLOGIES INC /CA
S-3/A, EX-23.1, 2000-06-21
PHARMACEUTICAL PREPARATIONS
Previous: GENELABS TECHNOLOGIES INC /CA, S-3/A, EX-5.1, 2000-06-21
Next: ALKERMES INC, 424B3, 2000-06-21



<PAGE>   1




                                                                   EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" in Amendment
No. 2 to the Registration Statement (Form S-3 No. 333-34630) and related
Prospectus of Genelabs Technologies, Inc. for the registration of 5,000,000
shares of its common stock and to the incorporation by reference therein of our
report dated February 10, 2000 with respect to the consolidated financial
statements of Genelabs Technologies, Inc. included in its Annual Report on Form
10-K/A for the year ended December 31, 1999, filed with the Securities and
Exchange Commission.





                                                         /s/ ERNST & YOUNG LLP
                                                        ----------------------




Palo Alto, California
June 21, 2000









© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission